MEDICLINIC INTERNATIONAL PLC - Notification of Major Interest in Mediclinic International plc shares

Notification of Major Interest in Mediclinic International plc shares

Mediclinic International plc
(Incorporated in England and Wales)
Company Number 8338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60

12 April 2017

Notification of Major Interest in Mediclinic International plc shares


1. Identity of the issuer or the underlying issuer
   of existing shares to which voting rights are                                           Mediclinic International plc
   download
 
2  Reason for the notification (please tick the appropriate box or boxes):

   An acquisition or disposal of voting rights                                                     x
   An acquisition or disposal of qualifying financial instruments which may result in the
   acquisition of shares already issued to which voting rights are attached
   An acquisition or disposal of instruments with similar economic effect to qualifying
   financial instruments
   An event changing the breakdown of voting rights
   Other (please specify):
   
3. Full name of person(s) subject to the
   notification obligation:                                            Coronation Asset Management (Pty) Ltd
  
4. Full name of shareholder(s)
   (if different from 3.):                                             N/A
   
5. Date of the transaction and date on
   which the threshold is crossed or                                   10 April 2017
   reached:

6. Date on which issuer notified:                                      11 April 2017

7. Threshold(s) that is/are crossed or                                 5%
   reached:

8. Notified details:
A: Voting rights attached to shares
Class/type of        Situation previous          Resulting situation after the triggering transaction
shares               to the triggering
                     transaction
if possible using    Number         Number       Number        Number of voting        % of voting rights
the ISIN CODE        of             of           of shares     rights
                     Shares         Voting       Direct        Direct     Indirect     Direct       Indirect
                                    Rights
GB00B8HX8Z88         36 852 189     36 852 189   37 677 189    37 677 189              5.11%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction
Type of financial          Expiration    Exercise/                 Number of voting           % of voting
instrument                 date          Conversion Period         rights that may be         rights
                                                                   acquired if the
                                                                   instrument is
                                                                   exercised/ converted.

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction
Type of financial     Exercise     Expiration   Exercise/      Number of voting rights      % of voting rights
instrument            price        date         Conversion     instrument refers to
                                                period
                                                                                            Nominal       Delta
Total (A+B+C)
Number of voting rights                                   Percentage of voting rights
37 677 189                                                5.11%

9. Chain of controlled undertakings through which the voting rights and/or the
   financial instruments are effectively held, if applicable:

Proxy Voting:

10. Name of the proxy holder:                                                    Coronation Asset Management (Pty) Ltd
11. Number of voting rights proxy holder will cease to hold:  
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name:                                                                Jamie Rowland
15. Contact telephone number:                                                    +27 21 680 2000

Mediclinic’s primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South
Africa and on the NSX in Namibia.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600

Date: 12/04/2017 08:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.